GARUDA THERAPEUTICS

garuda-therapeutics-logo

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

GARUDA THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2021-01-01

Address:
Natick, Massachusetts, United States

Country:
United States

Website Url:
http://www.garudatx.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
72 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Mobile Non Scaleable Content


Similar Organizations

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

gentibio-logo

GentiBio

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kyverna-therapeutics-logo

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

octant-bio-logo

Octant Bio

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

taysha-gene-therapies-logo

Taysha Gene Therapies

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

wugen-logo

Wugen

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies


Current Advisors List

carl-l-gordon_image

Carl L. Gordon Board Member @ Garuda Therapeutics
Board_member
2021-09-01

shaan-gandhi_image

Shaan Gandhi Board Member @ Garuda Therapeutics
Board_member
2021-09-01

rahul-singhvi_image

Rahul Singhvi Board Member @ Garuda Therapeutics
Board_member
2021-09-01

eric-aguiar_image

Eric Aguiar Board Member @ Garuda Therapeutics
Board_member
2021-09-01

Current Employees Featured

not_available_image

Dhvanit Shah
Dhvanit Shah Founder, President, and Chief Executive Officer @ Garuda Therapeutics
Founder, President, and Chief Executive Officer

james-desiderio_image

James Desiderio
James Desiderio Chief Regulatory Officer @ Garuda Therapeutics
Chief Regulatory Officer
2022-03-01

Founder


not_available_image

David Scadden

not_available_image

Dhvanit Shah

not_available_image

Sean Morrison

Investors List

mass-general-brigham-ventures_image

Mass General Brigham Ventures

Mass General Brigham Ventures investment in Series A - Garuda Therapeutics

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Series A - Garuda Therapeutics

northpond-ventures_image

Northpond Ventures

Northpond Ventures investment in Series A - Garuda Therapeutics

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series A - Garuda Therapeutics

monashee-investment_image

Monashee Investment Management

Monashee Investment Management investment in Series A - Garuda Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Garuda Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - Garuda Therapeutics

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series A - Garuda Therapeutics

resilience-e701_image

Resilience

Resilience investment in Series A - Garuda Therapeutics

Official Site Inspections

http://www.garudatx.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.81 K

  • Host name: 74-208-236-97.elastic-ssl.ui-r.com
  • IP address: 74.208.236.97
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Garuda Therapeutics" on Search Engine